Building on its track record for developing recyclable packaging solutions, Amcor will be conducting customer trials of the world’s first recyclable polyethylene (PE)-based thermoform blister packaging.
The new packaging, called AmSky, is designed to meet the stringent requirements of highly specialised and regulated pharmaceutical packaging, and creates a more sustainable alternative for the most in-demand healthcare packaging type.
This innovation also benefits from up to 70 per cent reduction in its carbon footprint, when compared to packaging alternatives on the market today.
“This exciting solution is a result of Amcor’s continued focus on advanced technology and growth, using the entire power of our global R&D network to bring recyclable solutions to our customers,” says William Jackson, Amcor’s chief technology officer for flexibles.
AmSky eliminates PVC from the packaging by using a PE thermoform blister and lidding film.
Amcor says PVC can make packaging recycling more difficult or contaminate other materials if consumers attempt to recycle it. By removing PVC, while retaining all the benefits of pre-existing blister packaging, Amcor has created a new, recyclable solution that benefits the entire recycling process.
“Amcor is deploying our unique innovation capabilities to solve the biggest and most significant issues in packaging today,” explains Peter Konieczny, Amcor’s chief commercial officer.
“With AmSky, Amcor has signalled our commitment to breakthrough innovation in the healthcare space, therefore, we remain the packaging partner of choice for our healthcare customers, generating close to $2bn in annual sales in this market.
“This new blister packaging solution will significantly enhance the ability of healthcare and pharmaceutical brands to put sustainability at the heart of their businesses.”
Amcor is currently working with several leading pharmaceutical companies to bring AmSky to market globally. The company expects AmSky to be available in the healthcare market by the second half of 2022.